April 28, 2011

  Specialists of the American pharmaceutical company «Merck & Co.» created a new drug for the treatment of Hepatitis C . This tool eliminates the disease much faster than any of the currently existing drugs.

Boceprevir - The drug, which in the near future US authorities will be given permission to use it as a means to fight against hepatitis C. Development of this drug is sort of a breakthrough in the treatment of hepatitis C virus in the last twenty years.

The development of an effective therapy Hepatitis C   scientists have spent fifteen years. The result of their work was a means of allowing the cure for a short period of time, quite a number of patients. To date, these indicators could not reach any of the known anti-hepatitis drugs.

Recently, the Office for the Control of Drug Administration will consider another drug to treat hepatitis C - telaprevir . The drug was developed by another US company - Vertex Pharmaceuticals.

The mechanism of action of drugs the same: there is a blocking protease enzymes, in which hepatitis C virus loses the ability to reproduce. Furthermore, increased immunity organism. According to experts, the sale of new drugs bring to their creators billions of dollars in profits.

Viral hepatitis C.   confident "walks" on the planet. Number of falling ill is growing every day. According to the World Health Organization today the number of carriers of a dangerous virus is 200 million people. According to other reputable medical organizations, this figure reaches 500 million infected. Each year, this figure increased by 10-15%.

The Russian official statistics hepatitis was first introduced in 1994. Then there were patients with virus to 3, 5% for every 100 thousand people. Every year, this figure shows a positive growth trend. Russia is a leader in the incidence of a dangerous virus. Currently registered in the country of 5 million people with hepatitis C, but it's official statistics. Experts believe that in fact there may be more positive.